MENU
+Compare
SARTF
Stock ticker: OTC
AS OF
Nov 10 closing price
Price
$209.67
Change
+$7.73 (+3.83%)
Capitalization
16.45B

SARTF Sartorius AG Forecast, Technical & Fundamental Analysis

Sartorius AG is a leading provider of bioprocessing solutions... Show more

SARTF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for SARTF with price predictions
Nov 12, 2025

SARTF sees MACD Histogram crosses below signal line

SARTF saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 04, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 46 instances where the indicator turned negative. In of the 46 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for SARTF moved out of overbought territory on November 04, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on November 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SARTF as a result. In of 63 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 56 cases where SARTF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The 50-day moving average for SARTF moved above the 200-day moving average on November 03, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

SARTF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 114 cases where SARTF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SARTF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.682) is normal, around the industry mean (10.242). P/E Ratio (94.006) is within average values for comparable stocks, (158.743). Projected Growth (PEG Ratio) (0.752) is also within normal values, averaging (2.733). Dividend Yield (0.004) settles around the average of (0.016) among similar stocks. P/S Ratio (3.552) is also within normal values, averaging (111.072).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SARTF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
SARTF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published Dividends

SARTF paid dividends on March 31, 2021

Sartorius AG SARTF Stock Dividends
А dividend of $0.70 per share was paid with a record date of March 31, 2021, and an ex-dividend date of March 29, 2021. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
Otto-Brenner-Strasse 20
Phone
+49 5513080
Employees
14614
Web
https://www.sartorius.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AVDS67.850.48
+0.72%
Avantis International Small Cp Eq ETF
BUFR33.83N/A
+0.01%
FT Vest Laddered Buffer ETF
OCTZ44.21N/A
N/A
TrueShares Structured Outcome OctoberETF
CCFE25.87N/A
N/A
Concourse Capital Focused Equity ETF
REM22.14-0.17
-0.76%
iShares Mortgage Real Estate Capped ETF

SARTF and Stocks

Correlation & Price change

A.I.dvisor tells us that SARTF and SOAGY have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SARTF and SOAGY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SARTF
1D Price
Change %
SARTF100%
N/A
SOAGY - SARTF
25%
Poorly correlated
-0.07%
RVTY - SARTF
25%
Poorly correlated
-0.19%
SRTOY - SARTF
24%
Poorly correlated
N/A
EXAS - SARTF
24%
Poorly correlated
+1.29%
WAT - SARTF
21%
Poorly correlated
+0.32%
More

Groups containing SARTF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SARTF
1D Price
Change %
SARTF100%
N/A
Pharmaceuticals
category (378 stocks)
13%
Poorly correlated
+0.02%
Pharmaceuticals: Other
category (103 stocks)
11%
Poorly correlated
+0.03%